Depreciation in USD of ABVC BIOPHARMA, INC. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Abvc Biopharma, Inc. quarterly/annual Depreciation history and change rate from Q1 2018 to Q3 2025.
  • Abvc Biopharma, Inc. Depreciation for the quarter ending September 30, 2025 was $5.82K, a 17% decline year-over-year.
  • Abvc Biopharma, Inc. Depreciation for the twelve months ending September 30, 2025 was $30K, a 2.65% increase year-over-year.
  • Abvc Biopharma, Inc. annual Depreciation for 2024 was $32K, a 12.2% increase from 2023.
  • Abvc Biopharma, Inc. annual Depreciation for 2023 was $28.5K, a 19.9% increase from 2022.
  • Abvc Biopharma, Inc. annual Depreciation for 2022 was $23.8K, a 98.4% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $30K $5.82K -$1.19K -17% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $31.2K $6.7K -$6.61K -49.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $37.8K $7.02K +$5.74K +446% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q4 2024 $32K $10.4K +$2.84K +37.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 $29.2K $7.01K -$446 -5.98% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 $29.6K $13.3K +$6.31K +90.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $23.3K $1.29K -$5.21K -80.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 $28.5K $7.58K Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 $7.46K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $6.49K +$1.08K +20% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2022 $5.41K +$2.48K +84.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2021 $21.4K $2.94K -$7.48K -71.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $28.9K $2.93K -$8.25K -73.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $37.1K $6.81K -$4.38K -39.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $41.5K $8.73K -$5.53K -38.8% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-17
Q2 2020 $47.1K $10.4K -$5.27K -33.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $52.3K $11.2K -$2.77K -19.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $55.1K $11.2K +$823 +7.94% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $54.3K $14.3K +$3.69K +34.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 $50.6K $15.7K +$4.44K +39.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $46.1K $13.9K +$2.52K +22.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 $43.6K $10.4K Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 $10.6K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 $11.3K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $11.4K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28

ABVC BIOPHARMA, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $32K +$3.49K +12.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $28.5K +$4.73K +19.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $23.8K +$11.8K +98.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $12K -$25.1K -67.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $37.1K -$17.9K -32.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $55.1K +$11.5K +26.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $43.6K Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.